Global Mirvetuximab Soravtansine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Mirvetuximab Soravtansine market size was valued at US$ 710 million in 2025 and is forecast to a readjusted size of US$ 2621 million by 2032 with a CAGR of 15.9% during review period.
Mirvetuximab Soravtansine is an antibody-drug conjugate (ADC) targeting folate receptor ? (FR?). It is covalently formed by conjugating a humanized anti-FR? monoclonal antibody, a cleavable linker, and the microtubule inhibitor DM4. The drug can specifically recognize and bind to highly expressed FR? on the surface of tumor cells, release cytotoxic payloads after endocytosis into cells, and precisely kill tumor cells. It is mainly used for the treatment of malignant tumors such as FR?-positive recurrent ovarian cancer. Featuring high targeting ability and strong anti-tumor activity, it provides an important targeted therapeutic option for patients with advanced ovarian cancer.In 2025, global Mirvetuximab Soravtansine production reached approximately 105,000–110,000 vials.
As a globally pioneering and the only approved FR?-targeted ADC drug, Mirvetuximab Soravtansine has established significant clinical and market advantages in the field of platinum-resistant ovarian cancer. Its core value lies in the high efficacy and low toxicity profile brought by its precise targeting mechanism, which effectively addresses the long-unmet clinical needs. The global market is mainly led by the United States, and with successive approvals and commercialization in major markets such as the European Union and China, the product has shown a trend of rapid growth. Supported by priority recommendations in authoritative guidelines, it has further driven continuous improvements in physician prescriptions and patient penetration. In China, the commercialization is led by Huadong Medicine, which has achieved early market access and rapid nationwide coverage through favorable innovative drug policies. The advantages of local channels and academic promotion are gradually unlocking market potential. Looking ahead, its market growth will rely on the continuous penetration of ovarian cancer indications on the one hand, and the potential clinical expansion into other FR?-highly-expressing tumors on the other. Meanwhile, it faces multiple constraints including limited accessibility due to high pricing, the progress of medical insurance coverage, and the development of competing products targeting the same target in the future. Overall, the market is expected to grow steadily while accompanied by uncertainties from competition and policy changes.
This report is a detailed and comprehensive analysis for global Mirvetuximab Soravtansine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Mirvetuximab Soravtansine market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Mirvetuximab Soravtansine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Mirvetuximab Soravtansine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Mirvetuximab Soravtansine market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Mirvetuximab Soravtansine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Mirvetuximab Soravtansine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Mirvetuximab Soravtansine, with price, sales quantity, revenue, and global market share of Mirvetuximab Soravtansine from 2021 to 2026.
Chapter 3, the Mirvetuximab Soravtansine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mirvetuximab Soravtansine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Mirvetuximab Soravtansine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Mirvetuximab Soravtansine.
Chapter 14 and 15, to describe Mirvetuximab Soravtansine sales channel, distributors, customers, research findings and conclusion.
Mirvetuximab Soravtansine is an antibody-drug conjugate (ADC) targeting folate receptor ? (FR?). It is covalently formed by conjugating a humanized anti-FR? monoclonal antibody, a cleavable linker, and the microtubule inhibitor DM4. The drug can specifically recognize and bind to highly expressed FR? on the surface of tumor cells, release cytotoxic payloads after endocytosis into cells, and precisely kill tumor cells. It is mainly used for the treatment of malignant tumors such as FR?-positive recurrent ovarian cancer. Featuring high targeting ability and strong anti-tumor activity, it provides an important targeted therapeutic option for patients with advanced ovarian cancer.In 2025, global Mirvetuximab Soravtansine production reached approximately 105,000–110,000 vials.
As a globally pioneering and the only approved FR?-targeted ADC drug, Mirvetuximab Soravtansine has established significant clinical and market advantages in the field of platinum-resistant ovarian cancer. Its core value lies in the high efficacy and low toxicity profile brought by its precise targeting mechanism, which effectively addresses the long-unmet clinical needs. The global market is mainly led by the United States, and with successive approvals and commercialization in major markets such as the European Union and China, the product has shown a trend of rapid growth. Supported by priority recommendations in authoritative guidelines, it has further driven continuous improvements in physician prescriptions and patient penetration. In China, the commercialization is led by Huadong Medicine, which has achieved early market access and rapid nationwide coverage through favorable innovative drug policies. The advantages of local channels and academic promotion are gradually unlocking market potential. Looking ahead, its market growth will rely on the continuous penetration of ovarian cancer indications on the one hand, and the potential clinical expansion into other FR?-highly-expressing tumors on the other. Meanwhile, it faces multiple constraints including limited accessibility due to high pricing, the progress of medical insurance coverage, and the development of competing products targeting the same target in the future. Overall, the market is expected to grow steadily while accompanied by uncertainties from competition and policy changes.
This report is a detailed and comprehensive analysis for global Mirvetuximab Soravtansine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Mirvetuximab Soravtansine market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Mirvetuximab Soravtansine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Mirvetuximab Soravtansine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Mirvetuximab Soravtansine market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Mirvetuximab Soravtansine
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Mirvetuximab Soravtansine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Lyophilized Powder for Injection
- Injectable Solution
- Mirvetuximab Soravtansine In Combination With Bevacizumab
- Mirvetuximab Soravtansine In Combination With Carboplatin
- Hospital
- Retail
- Online
- FR?-Positive Recurrent Ovarian Cancer
- Platinum-Resistant Epithelial Ovarian Cancer
- FR?-Highly Expressed Advanced Solid Tumors
- Others
- AbbVie
- Hangzhou Sino-American East China Pharmaceutical
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Mirvetuximab Soravtansine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Mirvetuximab Soravtansine, with price, sales quantity, revenue, and global market share of Mirvetuximab Soravtansine from 2021 to 2026.
Chapter 3, the Mirvetuximab Soravtansine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mirvetuximab Soravtansine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Mirvetuximab Soravtansine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Mirvetuximab Soravtansine.
Chapter 14 and 15, to describe Mirvetuximab Soravtansine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Mirvetuximab Soravtansine Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Lyophilized Powder for Injection
1.3.3 Injectable Solution
1.4 Market Analysis by Combination Medication
1.4.1 Overview: Global Mirvetuximab Soravtansine Consumption Value by Combination Medication: 2021 Versus 2025 Versus 2032
1.4.2 Mirvetuximab Soravtansine In Combination With Bevacizumab
1.4.3 Mirvetuximab Soravtansine In Combination With Carboplatin
1.5 Market Analysis by Sales Channels
1.5.1 Overview: Global Mirvetuximab Soravtansine Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
1.5.2 Hospital
1.5.3 Retail
1.5.4 Online
1.6 Market Analysis by Application
1.6.1 Overview: Global Mirvetuximab Soravtansine Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 FR?-Positive Recurrent Ovarian Cancer
1.6.3 Platinum-Resistant Epithelial Ovarian Cancer
1.6.4 FR?-Highly Expressed Advanced Solid Tumors
1.6.5 Others
1.7 Global Mirvetuximab Soravtansine Market Size & Forecast
1.7.1 Global Mirvetuximab Soravtansine Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Mirvetuximab Soravtansine Sales Quantity (2021-2032)
1.7.3 Global Mirvetuximab Soravtansine Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Mirvetuximab Soravtansine Product and Services
2.1.4 AbbVie Mirvetuximab Soravtansine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 AbbVie Recent Developments/Updates
2.2 Hangzhou Sino-American East China Pharmaceutical
2.2.1 Hangzhou Sino-American East China Pharmaceutical Details
2.2.2 Hangzhou Sino-American East China Pharmaceutical Major Business
2.2.3 Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Product and Services
2.2.4 Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Hangzhou Sino-American East China Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MIRVETUXIMAB SORAVTANSINE BY MANUFACTURER
3.1 Global Mirvetuximab Soravtansine Sales Quantity by Manufacturer (2021-2026)
3.2 Global Mirvetuximab Soravtansine Revenue by Manufacturer (2021-2026)
3.3 Global Mirvetuximab Soravtansine Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Mirvetuximab Soravtansine by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Mirvetuximab Soravtansine Manufacturer Market Share in 2025
3.4.3 Top 6 Mirvetuximab Soravtansine Manufacturer Market Share in 2025
3.5 Mirvetuximab Soravtansine Market: Overall Company Footprint Analysis
3.5.1 Mirvetuximab Soravtansine Market: Region Footprint
3.5.2 Mirvetuximab Soravtansine Market: Company Product Type Footprint
3.5.3 Mirvetuximab Soravtansine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Mirvetuximab Soravtansine Market Size by Region
4.1.1 Global Mirvetuximab Soravtansine Sales Quantity by Region (2021-2032)
4.1.2 Global Mirvetuximab Soravtansine Consumption Value by Region (2021-2032)
4.1.3 Global Mirvetuximab Soravtansine Average Price by Region (2021-2032)
4.2 North America Mirvetuximab Soravtansine Consumption Value (2021-2032)
4.3 Europe Mirvetuximab Soravtansine Consumption Value (2021-2032)
4.4 Asia-Pacific Mirvetuximab Soravtansine Consumption Value (2021-2032)
4.5 South America Mirvetuximab Soravtansine Consumption Value (2021-2032)
4.6 Middle East & Africa Mirvetuximab Soravtansine Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Mirvetuximab Soravtansine Sales Quantity by Type (2021-2032)
5.2 Global Mirvetuximab Soravtansine Consumption Value by Type (2021-2032)
5.3 Global Mirvetuximab Soravtansine Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Mirvetuximab Soravtansine Sales Quantity by Application (2021-2032)
6.2 Global Mirvetuximab Soravtansine Consumption Value by Application (2021-2032)
6.3 Global Mirvetuximab Soravtansine Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Mirvetuximab Soravtansine Sales Quantity by Type (2021-2032)
7.2 North America Mirvetuximab Soravtansine Sales Quantity by Application (2021-2032)
7.3 North America Mirvetuximab Soravtansine Market Size by Country
7.3.1 North America Mirvetuximab Soravtansine Sales Quantity by Country (2021-2032)
7.3.2 North America Mirvetuximab Soravtansine Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Mirvetuximab Soravtansine Sales Quantity by Type (2021-2032)
8.2 Europe Mirvetuximab Soravtansine Sales Quantity by Application (2021-2032)
8.3 Europe Mirvetuximab Soravtansine Market Size by Country
8.3.1 Europe Mirvetuximab Soravtansine Sales Quantity by Country (2021-2032)
8.3.2 Europe Mirvetuximab Soravtansine Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Mirvetuximab Soravtansine Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Mirvetuximab Soravtansine Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Mirvetuximab Soravtansine Market Size by Region
9.3.1 Asia-Pacific Mirvetuximab Soravtansine Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Mirvetuximab Soravtansine Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Mirvetuximab Soravtansine Sales Quantity by Type (2021-2032)
10.2 South America Mirvetuximab Soravtansine Sales Quantity by Application (2021-2032)
10.3 South America Mirvetuximab Soravtansine Market Size by Country
10.3.1 South America Mirvetuximab Soravtansine Sales Quantity by Country (2021-2032)
10.3.2 South America Mirvetuximab Soravtansine Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Mirvetuximab Soravtansine Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Mirvetuximab Soravtansine Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Mirvetuximab Soravtansine Market Size by Country
11.3.1 Middle East & Africa Mirvetuximab Soravtansine Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Mirvetuximab Soravtansine Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Mirvetuximab Soravtansine Market Drivers
12.2 Mirvetuximab Soravtansine Market Restraints
12.3 Mirvetuximab Soravtansine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Mirvetuximab Soravtansine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Mirvetuximab Soravtansine
13.3 Mirvetuximab Soravtansine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Mirvetuximab Soravtansine Typical Distributors
14.3 Mirvetuximab Soravtansine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Mirvetuximab Soravtansine Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Lyophilized Powder for Injection
1.3.3 Injectable Solution
1.4 Market Analysis by Combination Medication
1.4.1 Overview: Global Mirvetuximab Soravtansine Consumption Value by Combination Medication: 2021 Versus 2025 Versus 2032
1.4.2 Mirvetuximab Soravtansine In Combination With Bevacizumab
1.4.3 Mirvetuximab Soravtansine In Combination With Carboplatin
1.5 Market Analysis by Sales Channels
1.5.1 Overview: Global Mirvetuximab Soravtansine Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
1.5.2 Hospital
1.5.3 Retail
1.5.4 Online
1.6 Market Analysis by Application
1.6.1 Overview: Global Mirvetuximab Soravtansine Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 FR?-Positive Recurrent Ovarian Cancer
1.6.3 Platinum-Resistant Epithelial Ovarian Cancer
1.6.4 FR?-Highly Expressed Advanced Solid Tumors
1.6.5 Others
1.7 Global Mirvetuximab Soravtansine Market Size & Forecast
1.7.1 Global Mirvetuximab Soravtansine Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Mirvetuximab Soravtansine Sales Quantity (2021-2032)
1.7.3 Global Mirvetuximab Soravtansine Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Mirvetuximab Soravtansine Product and Services
2.1.4 AbbVie Mirvetuximab Soravtansine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 AbbVie Recent Developments/Updates
2.2 Hangzhou Sino-American East China Pharmaceutical
2.2.1 Hangzhou Sino-American East China Pharmaceutical Details
2.2.2 Hangzhou Sino-American East China Pharmaceutical Major Business
2.2.3 Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Product and Services
2.2.4 Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Hangzhou Sino-American East China Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MIRVETUXIMAB SORAVTANSINE BY MANUFACTURER
3.1 Global Mirvetuximab Soravtansine Sales Quantity by Manufacturer (2021-2026)
3.2 Global Mirvetuximab Soravtansine Revenue by Manufacturer (2021-2026)
3.3 Global Mirvetuximab Soravtansine Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Mirvetuximab Soravtansine by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Mirvetuximab Soravtansine Manufacturer Market Share in 2025
3.4.3 Top 6 Mirvetuximab Soravtansine Manufacturer Market Share in 2025
3.5 Mirvetuximab Soravtansine Market: Overall Company Footprint Analysis
3.5.1 Mirvetuximab Soravtansine Market: Region Footprint
3.5.2 Mirvetuximab Soravtansine Market: Company Product Type Footprint
3.5.3 Mirvetuximab Soravtansine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Mirvetuximab Soravtansine Market Size by Region
4.1.1 Global Mirvetuximab Soravtansine Sales Quantity by Region (2021-2032)
4.1.2 Global Mirvetuximab Soravtansine Consumption Value by Region (2021-2032)
4.1.3 Global Mirvetuximab Soravtansine Average Price by Region (2021-2032)
4.2 North America Mirvetuximab Soravtansine Consumption Value (2021-2032)
4.3 Europe Mirvetuximab Soravtansine Consumption Value (2021-2032)
4.4 Asia-Pacific Mirvetuximab Soravtansine Consumption Value (2021-2032)
4.5 South America Mirvetuximab Soravtansine Consumption Value (2021-2032)
4.6 Middle East & Africa Mirvetuximab Soravtansine Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Mirvetuximab Soravtansine Sales Quantity by Type (2021-2032)
5.2 Global Mirvetuximab Soravtansine Consumption Value by Type (2021-2032)
5.3 Global Mirvetuximab Soravtansine Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Mirvetuximab Soravtansine Sales Quantity by Application (2021-2032)
6.2 Global Mirvetuximab Soravtansine Consumption Value by Application (2021-2032)
6.3 Global Mirvetuximab Soravtansine Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Mirvetuximab Soravtansine Sales Quantity by Type (2021-2032)
7.2 North America Mirvetuximab Soravtansine Sales Quantity by Application (2021-2032)
7.3 North America Mirvetuximab Soravtansine Market Size by Country
7.3.1 North America Mirvetuximab Soravtansine Sales Quantity by Country (2021-2032)
7.3.2 North America Mirvetuximab Soravtansine Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Mirvetuximab Soravtansine Sales Quantity by Type (2021-2032)
8.2 Europe Mirvetuximab Soravtansine Sales Quantity by Application (2021-2032)
8.3 Europe Mirvetuximab Soravtansine Market Size by Country
8.3.1 Europe Mirvetuximab Soravtansine Sales Quantity by Country (2021-2032)
8.3.2 Europe Mirvetuximab Soravtansine Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Mirvetuximab Soravtansine Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Mirvetuximab Soravtansine Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Mirvetuximab Soravtansine Market Size by Region
9.3.1 Asia-Pacific Mirvetuximab Soravtansine Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Mirvetuximab Soravtansine Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Mirvetuximab Soravtansine Sales Quantity by Type (2021-2032)
10.2 South America Mirvetuximab Soravtansine Sales Quantity by Application (2021-2032)
10.3 South America Mirvetuximab Soravtansine Market Size by Country
10.3.1 South America Mirvetuximab Soravtansine Sales Quantity by Country (2021-2032)
10.3.2 South America Mirvetuximab Soravtansine Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Mirvetuximab Soravtansine Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Mirvetuximab Soravtansine Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Mirvetuximab Soravtansine Market Size by Country
11.3.1 Middle East & Africa Mirvetuximab Soravtansine Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Mirvetuximab Soravtansine Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Mirvetuximab Soravtansine Market Drivers
12.2 Mirvetuximab Soravtansine Market Restraints
12.3 Mirvetuximab Soravtansine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Mirvetuximab Soravtansine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Mirvetuximab Soravtansine
13.3 Mirvetuximab Soravtansine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Mirvetuximab Soravtansine Typical Distributors
14.3 Mirvetuximab Soravtansine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Mirvetuximab Soravtansine Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Mirvetuximab Soravtansine Consumption Value by Combination Medication, (USD Million), 2021 & 2025 & 2032
Table 3. Global Mirvetuximab Soravtansine Consumption Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 4. Global Mirvetuximab Soravtansine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. AbbVie Basic Information, Manufacturing Base and Competitors
Table 6. AbbVie Major Business
Table 7. AbbVie Mirvetuximab Soravtansine Product and Services
Table 8. AbbVie Mirvetuximab Soravtansine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. AbbVie Recent Developments/Updates
Table 10. Hangzhou Sino-American East China Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 11. Hangzhou Sino-American East China Pharmaceutical Major Business
Table 12. Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Product and Services
Table 13. Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Hangzhou Sino-American East China Pharmaceutical Recent Developments/Updates
Table 15. Global Mirvetuximab Soravtansine Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 16. Global Mirvetuximab Soravtansine Revenue by Manufacturer (2021-2026) & (USD Million)
Table 17. Global Mirvetuximab Soravtansine Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 18. Market Position of Manufacturers in Mirvetuximab Soravtansine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 19. Head Office and Mirvetuximab Soravtansine Production Site of Key Manufacturer
Table 20. Mirvetuximab Soravtansine Market: Company Product Type Footprint
Table 21. Mirvetuximab Soravtansine Market: Company Product Application Footprint
Table 22. Mirvetuximab Soravtansine New Market Entrants and Barriers to Market Entry
Table 23. Mirvetuximab Soravtansine Mergers, Acquisition, Agreements, and Collaborations
Table 24. Global Mirvetuximab Soravtansine Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 25. Global Mirvetuximab Soravtansine Sales Quantity by Region (2021-2026) & (Units)
Table 26. Global Mirvetuximab Soravtansine Sales Quantity by Region (2027-2032) & (Units)
Table 27. Global Mirvetuximab Soravtansine Consumption Value by Region (2021-2026) & (USD Million)
Table 28. Global Mirvetuximab Soravtansine Consumption Value by Region (2027-2032) & (USD Million)
Table 29. Global Mirvetuximab Soravtansine Average Price by Region (2021-2026) & (US$/Unit)
Table 30. Global Mirvetuximab Soravtansine Average Price by Region (2027-2032) & (US$/Unit)
Table 31. Global Mirvetuximab Soravtansine Sales Quantity by Type (2021-2026) & (Units)
Table 32. Global Mirvetuximab Soravtansine Sales Quantity by Type (2027-2032) & (Units)
Table 33. Global Mirvetuximab Soravtansine Consumption Value by Type (2021-2026) & (USD Million)
Table 34. Global Mirvetuximab Soravtansine Consumption Value by Type (2027-2032) & (USD Million)
Table 35. Global Mirvetuximab Soravtansine Average Price by Type (2021-2026) & (US$/Unit)
Table 36. Global Mirvetuximab Soravtansine Average Price by Type (2027-2032) & (US$/Unit)
Table 37. Global Mirvetuximab Soravtansine Sales Quantity by Application (2021-2026) & (Units)
Table 38. Global Mirvetuximab Soravtansine Sales Quantity by Application (2027-2032) & (Units)
Table 39. Global Mirvetuximab Soravtansine Consumption Value by Application (2021-2026) & (USD Million)
Table 40. Global Mirvetuximab Soravtansine Consumption Value by Application (2027-2032) & (USD Million)
Table 41. Global Mirvetuximab Soravtansine Average Price by Application (2021-2026) & (US$/Unit)
Table 42. Global Mirvetuximab Soravtansine Average Price by Application (2027-2032) & (US$/Unit)
Table 43. North America Mirvetuximab Soravtansine Sales Quantity by Type (2021-2026) & (Units)
Table 44. North America Mirvetuximab Soravtansine Sales Quantity by Type (2027-2032) & (Units)
Table 45. North America Mirvetuximab Soravtansine Sales Quantity by Application (2021-2026) & (Units)
Table 46. North America Mirvetuximab Soravtansine Sales Quantity by Application (2027-2032) & (Units)
Table 47. North America Mirvetuximab Soravtansine Sales Quantity by Country (2021-2026) & (Units)
Table 48. North America Mirvetuximab Soravtansine Sales Quantity by Country (2027-2032) & (Units)
Table 49. North America Mirvetuximab Soravtansine Consumption Value by Country (2021-2026) & (USD Million)
Table 50. North America Mirvetuximab Soravtansine Consumption Value by Country (2027-2032) & (USD Million)
Table 51. Europe Mirvetuximab Soravtansine Sales Quantity by Type (2021-2026) & (Units)
Table 52. Europe Mirvetuximab Soravtansine Sales Quantity by Type (2027-2032) & (Units)
Table 53. Europe Mirvetuximab Soravtansine Sales Quantity by Application (2021-2026) & (Units)
Table 54. Europe Mirvetuximab Soravtansine Sales Quantity by Application (2027-2032) & (Units)
Table 55. Europe Mirvetuximab Soravtansine Sales Quantity by Country (2021-2026) & (Units)
Table 56. Europe Mirvetuximab Soravtansine Sales Quantity by Country (2027-2032) & (Units)
Table 57. Europe Mirvetuximab Soravtansine Consumption Value by Country (2021-2026) & (USD Million)
Table 58. Europe Mirvetuximab Soravtansine Consumption Value by Country (2027-2032) & (USD Million)
Table 59. Asia-Pacific Mirvetuximab Soravtansine Sales Quantity by Type (2021-2026) & (Units)
Table 60. Asia-Pacific Mirvetuximab Soravtansine Sales Quantity by Type (2027-2032) & (Units)
Table 61. Asia-Pacific Mirvetuximab Soravtansine Sales Quantity by Application (2021-2026) & (Units)
Table 62. Asia-Pacific Mirvetuximab Soravtansine Sales Quantity by Application (2027-2032) & (Units)
Table 63. Asia-Pacific Mirvetuximab Soravtansine Sales Quantity by Region (2021-2026) & (Units)
Table 64. Asia-Pacific Mirvetuximab Soravtansine Sales Quantity by Region (2027-2032) & (Units)
Table 65. Asia-Pacific Mirvetuximab Soravtansine Consumption Value by Region (2021-2026) & (USD Million)
Table 66. Asia-Pacific Mirvetuximab Soravtansine Consumption Value by Region (2027-2032) & (USD Million)
Table 67. South America Mirvetuximab Soravtansine Sales Quantity by Type (2021-2026) & (Units)
Table 68. South America Mirvetuximab Soravtansine Sales Quantity by Type (2027-2032) & (Units)
Table 69. South America Mirvetuximab Soravtansine Sales Quantity by Application (2021-2026) & (Units)
Table 70. South America Mirvetuximab Soravtansine Sales Quantity by Application (2027-2032) & (Units)
Table 71. South America Mirvetuximab Soravtansine Sales Quantity by Country (2021-2026) & (Units)
Table 72. South America Mirvetuximab Soravtansine Sales Quantity by Country (2027-2032) & (Units)
Table 73. South America Mirvetuximab Soravtansine Consumption Value by Country (2021-2026) & (USD Million)
Table 74. South America Mirvetuximab Soravtansine Consumption Value by Country (2027-2032) & (USD Million)
Table 75. Middle East & Africa Mirvetuximab Soravtansine Sales Quantity by Type (2021-2026) & (Units)
Table 76. Middle East & Africa Mirvetuximab Soravtansine Sales Quantity by Type (2027-2032) & (Units)
Table 77. Middle East & Africa Mirvetuximab Soravtansine Sales Quantity by Application (2021-2026) & (Units)
Table 78. Middle East & Africa Mirvetuximab Soravtansine Sales Quantity by Application (2027-2032) & (Units)
Table 79. Middle East & Africa Mirvetuximab Soravtansine Sales Quantity by Country (2021-2026) & (Units)
Table 80. Middle East & Africa Mirvetuximab Soravtansine Sales Quantity by Country (2027-2032) & (Units)
Table 81. Middle East & Africa Mirvetuximab Soravtansine Consumption Value by Country (2021-2026) & (USD Million)
Table 82. Middle East & Africa Mirvetuximab Soravtansine Consumption Value by Country (2027-2032) & (USD Million)
Table 83. Mirvetuximab Soravtansine Raw Material
Table 84. Key Manufacturers of Mirvetuximab Soravtansine Raw Materials
Table 85. Mirvetuximab Soravtansine Typical Distributors
Table 86. Mirvetuximab Soravtansine Typical Customers
Table 1. Global Mirvetuximab Soravtansine Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Mirvetuximab Soravtansine Consumption Value by Combination Medication, (USD Million), 2021 & 2025 & 2032
Table 3. Global Mirvetuximab Soravtansine Consumption Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 4. Global Mirvetuximab Soravtansine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. AbbVie Basic Information, Manufacturing Base and Competitors
Table 6. AbbVie Major Business
Table 7. AbbVie Mirvetuximab Soravtansine Product and Services
Table 8. AbbVie Mirvetuximab Soravtansine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. AbbVie Recent Developments/Updates
Table 10. Hangzhou Sino-American East China Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 11. Hangzhou Sino-American East China Pharmaceutical Major Business
Table 12. Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Product and Services
Table 13. Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Hangzhou Sino-American East China Pharmaceutical Recent Developments/Updates
Table 15. Global Mirvetuximab Soravtansine Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 16. Global Mirvetuximab Soravtansine Revenue by Manufacturer (2021-2026) & (USD Million)
Table 17. Global Mirvetuximab Soravtansine Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 18. Market Position of Manufacturers in Mirvetuximab Soravtansine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 19. Head Office and Mirvetuximab Soravtansine Production Site of Key Manufacturer
Table 20. Mirvetuximab Soravtansine Market: Company Product Type Footprint
Table 21. Mirvetuximab Soravtansine Market: Company Product Application Footprint
Table 22. Mirvetuximab Soravtansine New Market Entrants and Barriers to Market Entry
Table 23. Mirvetuximab Soravtansine Mergers, Acquisition, Agreements, and Collaborations
Table 24. Global Mirvetuximab Soravtansine Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 25. Global Mirvetuximab Soravtansine Sales Quantity by Region (2021-2026) & (Units)
Table 26. Global Mirvetuximab Soravtansine Sales Quantity by Region (2027-2032) & (Units)
Table 27. Global Mirvetuximab Soravtansine Consumption Value by Region (2021-2026) & (USD Million)
Table 28. Global Mirvetuximab Soravtansine Consumption Value by Region (2027-2032) & (USD Million)
Table 29. Global Mirvetuximab Soravtansine Average Price by Region (2021-2026) & (US$/Unit)
Table 30. Global Mirvetuximab Soravtansine Average Price by Region (2027-2032) & (US$/Unit)
Table 31. Global Mirvetuximab Soravtansine Sales Quantity by Type (2021-2026) & (Units)
Table 32. Global Mirvetuximab Soravtansine Sales Quantity by Type (2027-2032) & (Units)
Table 33. Global Mirvetuximab Soravtansine Consumption Value by Type (2021-2026) & (USD Million)
Table 34. Global Mirvetuximab Soravtansine Consumption Value by Type (2027-2032) & (USD Million)
Table 35. Global Mirvetuximab Soravtansine Average Price by Type (2021-2026) & (US$/Unit)
Table 36. Global Mirvetuximab Soravtansine Average Price by Type (2027-2032) & (US$/Unit)
Table 37. Global Mirvetuximab Soravtansine Sales Quantity by Application (2021-2026) & (Units)
Table 38. Global Mirvetuximab Soravtansine Sales Quantity by Application (2027-2032) & (Units)
Table 39. Global Mirvetuximab Soravtansine Consumption Value by Application (2021-2026) & (USD Million)
Table 40. Global Mirvetuximab Soravtansine Consumption Value by Application (2027-2032) & (USD Million)
Table 41. Global Mirvetuximab Soravtansine Average Price by Application (2021-2026) & (US$/Unit)
Table 42. Global Mirvetuximab Soravtansine Average Price by Application (2027-2032) & (US$/Unit)
Table 43. North America Mirvetuximab Soravtansine Sales Quantity by Type (2021-2026) & (Units)
Table 44. North America Mirvetuximab Soravtansine Sales Quantity by Type (2027-2032) & (Units)
Table 45. North America Mirvetuximab Soravtansine Sales Quantity by Application (2021-2026) & (Units)
Table 46. North America Mirvetuximab Soravtansine Sales Quantity by Application (2027-2032) & (Units)
Table 47. North America Mirvetuximab Soravtansine Sales Quantity by Country (2021-2026) & (Units)
Table 48. North America Mirvetuximab Soravtansine Sales Quantity by Country (2027-2032) & (Units)
Table 49. North America Mirvetuximab Soravtansine Consumption Value by Country (2021-2026) & (USD Million)
Table 50. North America Mirvetuximab Soravtansine Consumption Value by Country (2027-2032) & (USD Million)
Table 51. Europe Mirvetuximab Soravtansine Sales Quantity by Type (2021-2026) & (Units)
Table 52. Europe Mirvetuximab Soravtansine Sales Quantity by Type (2027-2032) & (Units)
Table 53. Europe Mirvetuximab Soravtansine Sales Quantity by Application (2021-2026) & (Units)
Table 54. Europe Mirvetuximab Soravtansine Sales Quantity by Application (2027-2032) & (Units)
Table 55. Europe Mirvetuximab Soravtansine Sales Quantity by Country (2021-2026) & (Units)
Table 56. Europe Mirvetuximab Soravtansine Sales Quantity by Country (2027-2032) & (Units)
Table 57. Europe Mirvetuximab Soravtansine Consumption Value by Country (2021-2026) & (USD Million)
Table 58. Europe Mirvetuximab Soravtansine Consumption Value by Country (2027-2032) & (USD Million)
Table 59. Asia-Pacific Mirvetuximab Soravtansine Sales Quantity by Type (2021-2026) & (Units)
Table 60. Asia-Pacific Mirvetuximab Soravtansine Sales Quantity by Type (2027-2032) & (Units)
Table 61. Asia-Pacific Mirvetuximab Soravtansine Sales Quantity by Application (2021-2026) & (Units)
Table 62. Asia-Pacific Mirvetuximab Soravtansine Sales Quantity by Application (2027-2032) & (Units)
Table 63. Asia-Pacific Mirvetuximab Soravtansine Sales Quantity by Region (2021-2026) & (Units)
Table 64. Asia-Pacific Mirvetuximab Soravtansine Sales Quantity by Region (2027-2032) & (Units)
Table 65. Asia-Pacific Mirvetuximab Soravtansine Consumption Value by Region (2021-2026) & (USD Million)
Table 66. Asia-Pacific Mirvetuximab Soravtansine Consumption Value by Region (2027-2032) & (USD Million)
Table 67. South America Mirvetuximab Soravtansine Sales Quantity by Type (2021-2026) & (Units)
Table 68. South America Mirvetuximab Soravtansine Sales Quantity by Type (2027-2032) & (Units)
Table 69. South America Mirvetuximab Soravtansine Sales Quantity by Application (2021-2026) & (Units)
Table 70. South America Mirvetuximab Soravtansine Sales Quantity by Application (2027-2032) & (Units)
Table 71. South America Mirvetuximab Soravtansine Sales Quantity by Country (2021-2026) & (Units)
Table 72. South America Mirvetuximab Soravtansine Sales Quantity by Country (2027-2032) & (Units)
Table 73. South America Mirvetuximab Soravtansine Consumption Value by Country (2021-2026) & (USD Million)
Table 74. South America Mirvetuximab Soravtansine Consumption Value by Country (2027-2032) & (USD Million)
Table 75. Middle East & Africa Mirvetuximab Soravtansine Sales Quantity by Type (2021-2026) & (Units)
Table 76. Middle East & Africa Mirvetuximab Soravtansine Sales Quantity by Type (2027-2032) & (Units)
Table 77. Middle East & Africa Mirvetuximab Soravtansine Sales Quantity by Application (2021-2026) & (Units)
Table 78. Middle East & Africa Mirvetuximab Soravtansine Sales Quantity by Application (2027-2032) & (Units)
Table 79. Middle East & Africa Mirvetuximab Soravtansine Sales Quantity by Country (2021-2026) & (Units)
Table 80. Middle East & Africa Mirvetuximab Soravtansine Sales Quantity by Country (2027-2032) & (Units)
Table 81. Middle East & Africa Mirvetuximab Soravtansine Consumption Value by Country (2021-2026) & (USD Million)
Table 82. Middle East & Africa Mirvetuximab Soravtansine Consumption Value by Country (2027-2032) & (USD Million)
Table 83. Mirvetuximab Soravtansine Raw Material
Table 84. Key Manufacturers of Mirvetuximab Soravtansine Raw Materials
Table 85. Mirvetuximab Soravtansine Typical Distributors
Table 86. Mirvetuximab Soravtansine Typical Customers
LIST OF FIGURES
Figure 1. Mirvetuximab Soravtansine Picture
Figure 2. Global Mirvetuximab Soravtansine Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Mirvetuximab Soravtansine Revenue Market Share by Type in 2025
Figure 4. Lyophilized Powder for Injection Examples
Figure 5. Injectable Solution Examples
Figure 6. Global Mirvetuximab Soravtansine Revenue by Combination Medication, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Mirvetuximab Soravtansine Revenue Market Share by Combination Medication in 2025
Figure 8. Mirvetuximab Soravtansine In Combination With Bevacizumab Examples
Figure 9. Mirvetuximab Soravtansine In Combination With Carboplatin Examples
Figure 10. Global Mirvetuximab Soravtansine Revenue by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Mirvetuximab Soravtansine Revenue Market Share by Sales Channels in 2025
Figure 12. Hospital Examples
Figure 13. Retail Examples
Figure 14. Online Examples
Figure 15. Global Mirvetuximab Soravtansine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 16. Global Mirvetuximab Soravtansine Revenue Market Share by Application in 2025
Figure 17. FR?-Positive Recurrent Ovarian Cancer Examples
Figure 18. Platinum-Resistant Epithelial Ovarian Cancer Examples
Figure 19. FR?-Highly Expressed Advanced Solid Tumors Examples
Figure 20. Others Examples
Figure 21. Global Mirvetuximab Soravtansine Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 22. Global Mirvetuximab Soravtansine Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 23. Global Mirvetuximab Soravtansine Sales Quantity (2021-2032) & (Units)
Figure 24. Global Mirvetuximab Soravtansine Price (2021-2032) & (US$/Unit)
Figure 25. Global Mirvetuximab Soravtansine Sales Quantity Market Share by Manufacturer in 2025
Figure 26. Global Mirvetuximab Soravtansine Revenue Market Share by Manufacturer in 2025
Figure 27. Producer Shipments of Mirvetuximab Soravtansine by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 28. Top 3 Mirvetuximab Soravtansine Manufacturer (Revenue) Market Share in 2025
Figure 29. Top 6 Mirvetuximab Soravtansine Manufacturer (Revenue) Market Share in 2025
Figure 30. Global Mirvetuximab Soravtansine Sales Quantity Market Share by Region (2021-2032)
Figure 31. Global Mirvetuximab Soravtansine Consumption Value Market Share by Region (2021-2032)
Figure 32. North America Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 33. Europe Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 34. Asia-Pacific Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 35. South America Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 36. Middle East & Africa Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 37. Global Mirvetuximab Soravtansine Sales Quantity Market Share by Type (2021-2032)
Figure 38. Global Mirvetuximab Soravtansine Consumption Value Market Share by Type (2021-2032)
Figure 39. Global Mirvetuximab Soravtansine Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. Global Mirvetuximab Soravtansine Sales Quantity Market Share by Application (2021-2032)
Figure 41. Global Mirvetuximab Soravtansine Revenue Market Share by Application (2021-2032)
Figure 42. Global Mirvetuximab Soravtansine Average Price by Application (2021-2032) & (US$/Unit)
Figure 43. North America Mirvetuximab Soravtansine Sales Quantity Market Share by Type (2021-2032)
Figure 44. North America Mirvetuximab Soravtansine Sales Quantity Market Share by Application (2021-2032)
Figure 45. North America Mirvetuximab Soravtansine Sales Quantity Market Share by Country (2021-2032)
Figure 46. North America Mirvetuximab Soravtansine Consumption Value Market Share by Country (2021-2032)
Figure 47. United States Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe Mirvetuximab Soravtansine Sales Quantity Market Share by Type (2021-2032)
Figure 51. Europe Mirvetuximab Soravtansine Sales Quantity Market Share by Application (2021-2032)
Figure 52. Europe Mirvetuximab Soravtansine Sales Quantity Market Share by Country (2021-2032)
Figure 53. Europe Mirvetuximab Soravtansine Consumption Value Market Share by Country (2021-2032)
Figure 54. Germany Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 55. France Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 56. United Kingdom Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 57. Russia Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 58. Italy Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 59. Asia-Pacific Mirvetuximab Soravtansine Sales Quantity Market Share by Type (2021-2032)
Figure 60. Asia-Pacific Mirvetuximab Soravtansine Sales Quantity Market Share by Application (2021-2032)
Figure 61. Asia-Pacific Mirvetuximab Soravtansine Sales Quantity Market Share by Region (2021-2032)
Figure 62. Asia-Pacific Mirvetuximab Soravtansine Consumption Value Market Share by Region (2021-2032)
Figure 63. China Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 64. Japan Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 65. South Korea Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 66. India Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 67. Southeast Asia Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 68. Australia Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 69. South America Mirvetuximab Soravtansine Sales Quantity Market Share by Type (2021-2032)
Figure 70. South America Mirvetuximab Soravtansine Sales Quantity Market Share by Application (2021-2032)
Figure 71. South America Mirvetuximab Soravtansine Sales Quantity Market Share by Country (2021-2032)
Figure 72. South America Mirvetuximab Soravtansine Consumption Value Market Share by Country (2021-2032)
Figure 73. Brazil Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 74. Argentina Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 75. Middle East & Africa Mirvetuximab Soravtansine Sales Quantity Market Share by Type (2021-2032)
Figure 76. Middle East & Africa Mirvetuximab Soravtansine Sales Quantity Market Share by Application (2021-2032)
Figure 77. Middle East & Africa Mirvetuximab Soravtansine Sales Quantity Market Share by Country (2021-2032)
Figure 78. Middle East & Africa Mirvetuximab Soravtansine Consumption Value Market Share by Country (2021-2032)
Figure 79. Turkey Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 80. Egypt Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 81. Saudi Arabia Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 82. South Africa Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 83. Mirvetuximab Soravtansine Market Drivers
Figure 84. Mirvetuximab Soravtansine Market Restraints
Figure 85. Mirvetuximab Soravtansine Market Trends
Figure 86. Porters Five Forces Analysis
Figure 87. Manufacturing Cost Structure Analysis of Mirvetuximab Soravtansine in 2025
Figure 88. Manufacturing Process Analysis of Mirvetuximab Soravtansine
Figure 89. Mirvetuximab Soravtansine Industrial Chain
Figure 90. Sales Channel: Direct to End-User vs Distributors
Figure 91. Direct Channel Pros & Cons
Figure 92. Indirect Channel Pros & Cons
Figure 93. Methodology
Figure 94. Research Process and Data Source
Figure 1. Mirvetuximab Soravtansine Picture
Figure 2. Global Mirvetuximab Soravtansine Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Mirvetuximab Soravtansine Revenue Market Share by Type in 2025
Figure 4. Lyophilized Powder for Injection Examples
Figure 5. Injectable Solution Examples
Figure 6. Global Mirvetuximab Soravtansine Revenue by Combination Medication, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Mirvetuximab Soravtansine Revenue Market Share by Combination Medication in 2025
Figure 8. Mirvetuximab Soravtansine In Combination With Bevacizumab Examples
Figure 9. Mirvetuximab Soravtansine In Combination With Carboplatin Examples
Figure 10. Global Mirvetuximab Soravtansine Revenue by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Mirvetuximab Soravtansine Revenue Market Share by Sales Channels in 2025
Figure 12. Hospital Examples
Figure 13. Retail Examples
Figure 14. Online Examples
Figure 15. Global Mirvetuximab Soravtansine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 16. Global Mirvetuximab Soravtansine Revenue Market Share by Application in 2025
Figure 17. FR?-Positive Recurrent Ovarian Cancer Examples
Figure 18. Platinum-Resistant Epithelial Ovarian Cancer Examples
Figure 19. FR?-Highly Expressed Advanced Solid Tumors Examples
Figure 20. Others Examples
Figure 21. Global Mirvetuximab Soravtansine Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 22. Global Mirvetuximab Soravtansine Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 23. Global Mirvetuximab Soravtansine Sales Quantity (2021-2032) & (Units)
Figure 24. Global Mirvetuximab Soravtansine Price (2021-2032) & (US$/Unit)
Figure 25. Global Mirvetuximab Soravtansine Sales Quantity Market Share by Manufacturer in 2025
Figure 26. Global Mirvetuximab Soravtansine Revenue Market Share by Manufacturer in 2025
Figure 27. Producer Shipments of Mirvetuximab Soravtansine by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 28. Top 3 Mirvetuximab Soravtansine Manufacturer (Revenue) Market Share in 2025
Figure 29. Top 6 Mirvetuximab Soravtansine Manufacturer (Revenue) Market Share in 2025
Figure 30. Global Mirvetuximab Soravtansine Sales Quantity Market Share by Region (2021-2032)
Figure 31. Global Mirvetuximab Soravtansine Consumption Value Market Share by Region (2021-2032)
Figure 32. North America Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 33. Europe Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 34. Asia-Pacific Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 35. South America Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 36. Middle East & Africa Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 37. Global Mirvetuximab Soravtansine Sales Quantity Market Share by Type (2021-2032)
Figure 38. Global Mirvetuximab Soravtansine Consumption Value Market Share by Type (2021-2032)
Figure 39. Global Mirvetuximab Soravtansine Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. Global Mirvetuximab Soravtansine Sales Quantity Market Share by Application (2021-2032)
Figure 41. Global Mirvetuximab Soravtansine Revenue Market Share by Application (2021-2032)
Figure 42. Global Mirvetuximab Soravtansine Average Price by Application (2021-2032) & (US$/Unit)
Figure 43. North America Mirvetuximab Soravtansine Sales Quantity Market Share by Type (2021-2032)
Figure 44. North America Mirvetuximab Soravtansine Sales Quantity Market Share by Application (2021-2032)
Figure 45. North America Mirvetuximab Soravtansine Sales Quantity Market Share by Country (2021-2032)
Figure 46. North America Mirvetuximab Soravtansine Consumption Value Market Share by Country (2021-2032)
Figure 47. United States Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe Mirvetuximab Soravtansine Sales Quantity Market Share by Type (2021-2032)
Figure 51. Europe Mirvetuximab Soravtansine Sales Quantity Market Share by Application (2021-2032)
Figure 52. Europe Mirvetuximab Soravtansine Sales Quantity Market Share by Country (2021-2032)
Figure 53. Europe Mirvetuximab Soravtansine Consumption Value Market Share by Country (2021-2032)
Figure 54. Germany Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 55. France Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 56. United Kingdom Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 57. Russia Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 58. Italy Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 59. Asia-Pacific Mirvetuximab Soravtansine Sales Quantity Market Share by Type (2021-2032)
Figure 60. Asia-Pacific Mirvetuximab Soravtansine Sales Quantity Market Share by Application (2021-2032)
Figure 61. Asia-Pacific Mirvetuximab Soravtansine Sales Quantity Market Share by Region (2021-2032)
Figure 62. Asia-Pacific Mirvetuximab Soravtansine Consumption Value Market Share by Region (2021-2032)
Figure 63. China Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 64. Japan Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 65. South Korea Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 66. India Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 67. Southeast Asia Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 68. Australia Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 69. South America Mirvetuximab Soravtansine Sales Quantity Market Share by Type (2021-2032)
Figure 70. South America Mirvetuximab Soravtansine Sales Quantity Market Share by Application (2021-2032)
Figure 71. South America Mirvetuximab Soravtansine Sales Quantity Market Share by Country (2021-2032)
Figure 72. South America Mirvetuximab Soravtansine Consumption Value Market Share by Country (2021-2032)
Figure 73. Brazil Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 74. Argentina Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 75. Middle East & Africa Mirvetuximab Soravtansine Sales Quantity Market Share by Type (2021-2032)
Figure 76. Middle East & Africa Mirvetuximab Soravtansine Sales Quantity Market Share by Application (2021-2032)
Figure 77. Middle East & Africa Mirvetuximab Soravtansine Sales Quantity Market Share by Country (2021-2032)
Figure 78. Middle East & Africa Mirvetuximab Soravtansine Consumption Value Market Share by Country (2021-2032)
Figure 79. Turkey Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 80. Egypt Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 81. Saudi Arabia Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 82. South Africa Mirvetuximab Soravtansine Consumption Value (2021-2032) & (USD Million)
Figure 83. Mirvetuximab Soravtansine Market Drivers
Figure 84. Mirvetuximab Soravtansine Market Restraints
Figure 85. Mirvetuximab Soravtansine Market Trends
Figure 86. Porters Five Forces Analysis
Figure 87. Manufacturing Cost Structure Analysis of Mirvetuximab Soravtansine in 2025
Figure 88. Manufacturing Process Analysis of Mirvetuximab Soravtansine
Figure 89. Mirvetuximab Soravtansine Industrial Chain
Figure 90. Sales Channel: Direct to End-User vs Distributors
Figure 91. Direct Channel Pros & Cons
Figure 92. Indirect Channel Pros & Cons
Figure 93. Methodology
Figure 94. Research Process and Data Source
